Please assess the completion status of the following clinical trial:

Trial Title: Splanchnic Nerve Anesthesia in Heart Failure

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of heart failure (HF)~* Prior admissions for decompensated HF~* Symptomatic with dyspnea with clinical, radiographic or echocardiographic signs of fluid overload~* On a stable HF drug regimen prior to admission~* Anticipated hospital stay of at least 2 nights following catheterization procedure~Exclusion Criteria:~* Ongoing treatment with oral anticoagulation other than aspirin~* Immunosuppressive medications for solid organ transplant~* Acute MI (STEMI or NSTEMI) within 7 days~* Evidence of cardiogenic shock within 48 hours~* Systolic blood pressure \< 90 mmHg or \>180 mmHg~* Restrictive or constrictive cardiomyopathy~* Chronic kidney disease stage 3 or higher due to primary renal pathology~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Regional nerve anesthesia (Type: EXPERIMENTAL): Regional nerve anesthesia of splanchnic nerve

Based on this trial design, predict the completion outcome and termination type (if applicable).